Spadin
Sortilin propeptide fragment
A peptide derived from the sortilin propeptide, studied in preclinical models as a TREK-1 potassium channel blocker in the context of mood regulation. Preclinical only.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Not approved for human use; no public label defines handling.
References
- PubChem compound record
- Neuropharmacology 2012: spadin and absence of TREK-1-related side effects
- Psychopharmacology 2015: retroinverso analogs of spadin
Read the source
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.